About MATRIKS BIOTEK


Prof. Haluk Ataoglu MD, PhD (Microbiology & Immunology)

Founder of MATRIKS BIOTEK

Matriks Biotechnology, founded by Prof. Haluk Ataoglu in 2002, specializes in life sciences and biotechnology, developing products to improve global health. The company was the first to produce and commercialize ELISA kits for monitoring biological drugs under the brand SHIKARI® since 2008. These kits help optimize drug dosing and improve cost-effectiveness in treatment. During the COVID-19 pandemic, Matriks developed 16 unique CoronaHunter® ELISA kits for measuring antibodies against various viral proteins. With 91 ELISA kits for biological drugs and 16 for COVID-19 antibodies, the company has 106 products in total. Matriks allocates half of its revenue to R&D, exporting 95% of its production to over 40 countries.

شركة ماتريكس للتكنولوجيا الحيوية، التي أسسها البروفيسور هالوك أتاوغلو في عام 2002، متخصصة في علوم الحياة والتكنولوجيا الحيوية، وتعمل على تطوير منتجات لتحسين الصحة العالمية. كانت الشركة أول من أنتج وطرح في الأسواق مجموعات ELISA لمراقبة الأدوية البيولوجية تحت العلامة التجارية SHIKARI® منذ عام 2008. تساعد هذه المجموعات في تحسين جرعات الأدوية وزيادة الفعالية من حيث التكلفة في العلاج. خلال جائحة كوفيد-19، طورت ماتريكس 16 مجموعة ELISA فريدة من نوعها تحت اسم CoronaHunter® لقياس الأجسام المضادة ضد مختلف البروتينات الفيروسية. مع 91 مجموعة ELISA للأدوية البيولوجية و16 مجموعة للأجسام المضادة لكوفيد-19، تمتلك الشركة 106 منتجًا في المجمل. تخصّص ماتريكس نصف إيراداتها للبحث والتطوير، وتصدّر 95% من إنتاجها إلى أكثر من 40 دولة.

SHIKARI® ELISA KITS

  • Each kit’s dynamic measurement range optimized for Cmax-Cmin (trough) values of the drugs. Also, researchers can also measure biological levels of the drugs in human, mouse, rat and monkey serum or plasma samples for pharmacokinetic studies.

  • More than 150 publications has been made by using SHIKARI® ELISA kits.

  • All SHIKARI® ELISA kits are validated in compliance with international standards and easy to publish results.

  • Quantitative ELISA kits for anti-drug antibodies (immunogenicity) with confirmation reagent available for 18 different biological drugs. Matriks Biotek® is the first biotechnology company which produced ELISA kits for Remsima® (Infliximab Biosimilar CT-P13). Kits for Remsima® includes quantitative free drug detection kits, qualitative Anti-Remsima® detection kits and total antibody detection kits for Remsima®.

  • Total antibody (DUO) kits have been developed to identify anti-drug antibodies that are bound by drugs in the serum and cannot be determined by free antibody detection kits. Matriks Biotek® developed total antibody detection kits for 3 different drugs: Infliximab (Remicade®, Remsima®) and Adalimumab (Humira®). These DUO kits also measure free anti-drug antibodies simultaneously allowing comparisons between total and free anti-drug antibodies giving semi-quantitative results. Kits are unique in the market. Total antibody detection kit development studies for different drugs are ongoing, please inquire.

  • Quantitative ADA detection kits include confirmation reagent to eliminate false positives when reporting the results. Unique in the market.

  • Inter and intra assay CV to fulfill requirements for FDA & EMEA.

  • High recovery rates (%85-115)

  • Low sample volumes (10-25 µl) even if you have very small samples such as mouse serum

  • All liquid and highly stabilized ready to use reagents

  • Delivery is at room temperature. Cost saver!

  • The highest quality material used.

Microplates NUNC®, Perfect binding of proteins minimum %CV across the entire plate and perfect match with our proprietary blocking buffer almost no background with very long shelf life

Plastic bottles Nalgene® very durable with perfect surface property

Glass vials Schott® used for standard containers; vigorously tested. No protein binding clear glass w/ cap when compared to other brands

  • All kits are in 96 well format and you can run as much as 90 samples from each kit.

  • Time saver: Short incubation times for biologics testing (70-140 min)

  • 1 year expiry date

  • Short delivery times

  • Project development for custom ELISA kits to measure PK and immunogenicity for your specific biosimilar or original molecule.

  • Kits are suitable for biosimilar work. Kits utilize recombinant human proteins ligand binding assay

  • No radioactivity

  • All Shikari® ELISA kits are produced under ISO 13485 quality system and have CE IVD mark.

Hunter, one that pursues something with great desire, searching and finding it out.

 





التصنيفات